Xiaochuan Huo, MD 🇨🇳 (@xiaochuanhuo) 's Twitter Profile
Xiaochuan Huo, MD 🇨🇳

@xiaochuanhuo

Neurointervention, Interventional Neurology, Beijing Anzhen Hospital, Capital Medical University,Chinese Stroke Association #ANGEL_ASPECT #ANGEL_TNK trial

ID: 1472785147141718016

calendar_today20-12-2021 04:25:39

240 Tweet

602 Followers

555 Following

Dileep R. Yavagal (@dyavagal) 's Twitter Profile Photo

Abstracts open for the best stroke and Neurointerventional meeting of the year!!! Don’t believe me? Take a look at what everyone is saying when you click on the video below.

Tudor G. Jovin, MD (@tudorgjovin) 's Twitter Profile Photo

Check out our editorial just published in @JAMA. TESLA's unique feature is selection up to 24 hrs based on CT (ASPECTS 2-5) alone. Findings (including unpublished +ve results at 12 months) confirm that advanced imaging is not necessary even beyond 6 hrs. jamanetwork.com/journals/jama/…

Stroke and Vascular Neurology (@svn_csa) 's Twitter Profile Photo

Intra-arterial tenecteplase after successful endovascular therapy (ANGEL-TNK): protocol of a multicentre, open-label, blinded end-point, prospective, randomised trial #ANGEL-TNK #tenecteplase #EVT svn.bmj.com/content/early/…

Intra-arterial tenecteplase after successful endovascular therapy (ANGEL-TNK): protocol of a multicentre, open-label, blinded end-point, prospective, randomised trial #ANGEL-TNK #tenecteplase #EVT

svn.bmj.com/content/early/…
Fawaz Al-Mufti, MD, FSVIN (@almuftifawaz) 's Twitter Profile Photo

"You can't manage what you don't measure." — Peter Drucker. @SVINsociety's Mission Thrombectomy's latest publication allows us to measure the major disparity in access to stroke surgery by through a novel scoring system that factors in public awareness, EMS transportation, stroke

"You can't manage what you don't measure." — Peter Drucker.

@SVINsociety's <a href="/MThrombectomy/">Mission Thrombectomy</a>'s latest publication allows us to measure the major disparity in access to stroke surgery by through a novel scoring system that factors in public awareness, EMS transportation, stroke
AshuJadhav (@ashupjadhav) 's Twitter Profile Photo

Recanalization Does Not Always Equate to Reperfusion: No-Reflow Phenomenon After Successful Thrombectomy | Stroke ahajournals.org/doi/abs/10.116…

Recanalization Does Not Always Equate to Reperfusion: No-Reflow Phenomenon After Successful Thrombectomy | Stroke ahajournals.org/doi/abs/10.116…
SVIN (@svinsociety) 's Twitter Profile Photo

🌟Join SVIN Mission Thrombectomy at the AHA/ASA International Stroke Conference!🌟 Attending the American Heart Association/American Stroke Association International Stroke Conference in Los Angeles? Don’t miss an evening of networking, collaboration, and great conversation with

🌟Join SVIN Mission Thrombectomy at the AHA/ASA International Stroke Conference!🌟
Attending the American Heart Association/American Stroke Association International Stroke Conference in Los Angeles? Don’t miss an evening of networking, collaboration, and great conversation with
AHA Science (@ahascience) 's Twitter Profile Photo

In patients w/ acute large vessel occlusion presenting between 4.5 to 24 hours, did intra-arterial tenecteplase after successful thrombectomy result in a greater likelihood of excellent neurological outcome at 90 days? Find out at #ISC25 where the ANGEL-TNK will be presented.

Thanh Lam "Lance" Tran (@lance_tran_) 's Twitter Profile Photo

Dr Huo presents POSITIVE results from Angel-TNK administering adjunct IA TNK LVO pts with eTICI 2b50 to 3, primary outcome of mRS 0-1. #ISC25 🧑‍⚕️Note the details on administration of IA TNK 👍does not seem to increase sICH risk 🛑limitations: 🇨🇳, open-label, excl IVT recipients

Dr Huo presents POSITIVE results from Angel-TNK administering adjunct IA TNK LVO pts with eTICI 2b50 to 3, primary outcome of mRS 0-1. #ISC25

🧑‍⚕️Note the details on administration of IA TNK
👍does not seem to increase sICH risk
🛑limitations: 🇨🇳, open-label, excl IVT recipients
Stroke AHA/ASA (@strokeaha_asa) 's Twitter Profile Photo

Promising results to consider with post-thrombectomy thrombolytics in LVO pts as shown in PEARL and ANGEL-TNK results… Is this the answer to address the occlusive disease beyond what we see? #ISC25

Promising results to consider with post-thrombectomy thrombolytics in LVO pts as shown in PEARL and ANGEL-TNK results… Is this the answer to address the occlusive disease beyond what we see?  #ISC25
Umberto Pensato 🇮🇹 🇨🇦 (@upensato) 's Twitter Profile Photo

Two new positive trials (PEARL, ANGEL-TNK) investigating intra-arterial thrombolysis after successful recanalization, regardless time window and IVT pre EVT (even though secondary outcomes less convincing) #ISC25

Two new positive trials (PEARL, ANGEL-TNK) investigating intra-arterial thrombolysis after successful recanalization, regardless time window and IVT pre EVT (even though secondary outcomes less convincing) #ISC25
American Heart News (@heartnews) 's Twitter Profile Photo

VIDEO: Late-breaking science - Removing large brain artery clot, chased with clot-buster shot may improve stroke outcomes (LB38). Xiaochuan Huo, M.D., Ph.D., lead author of the study discusses the ANGEL-TNK. #ISC25 spr.ly/6019IK4Zt

Bijoy K Menon (@bijoymenon) 's Twitter Profile Photo

Dr Wang is a tireless crusader for that best of tools, the large RCT! His body of work has been influential in shaping stroke treatment for millions! Inspirational stroke scientist and an even better human! AHA Science Stroke and Vascular Neurology Tudor G. Jovin, MD LaurenHSansing

Umberto Pensato 🇮🇹 🇨🇦 (@upensato) 's Twitter Profile Photo

Take-home messages from #ISC25: ❌thrombectomy has likely achieved a ceiling effect (3 negative MeVO trial) 💉no-reflow phenomenon is real (positive trials of IA-TNK/tPA post-TICI2b/3) 💊 anti-GLP1s are the new statins (super effective) 🩸the clock ticks faster in ICH (code-ICH)

NeurologyLive® (@neurology_live) 's Twitter Profile Photo

📹 🗣️During an interview at #ISC25, Xiaochuan Huo, MD 🇨🇳, of Beijing Anzhen Hospital, talked about the key clinical implications of recent findings from the ANGEL-TNK trial of intra-arterial tenecteplase in #stroke. Stay tuned! ❤️📈 AHAMeetings AHA Science American Heart Association

NeuroNews (@nn_publishing) 's Twitter Profile Photo

Removing a blood clot from a large brain artery via EVT, then injecting #Tenecteplase, has resulted in stroke survivors being more likely to experience a better functional outcome when compared to those receiving standard clot removal Xiaochuan Huo, MD 🇨🇳 neuronewsinternational.com/chasing-evt-wi…

Stroke AHA/ASA (@strokeaha_asa) 's Twitter Profile Photo

#STROKE: Topical review by Liqi Shu et al. critically appraises the literature on perioperative stroke and identifies promising areas for future research. #AHAJournals ahajrnls.org/4na5FCh Thanh Nguyen 🇺🇦 @shadiyaghi2 Nicole B. Sur, MD Brown Neurology

#STROKE: Topical review by <a href="/ShuLiqi/">Liqi Shu</a> et al. critically appraises the literature on perioperative stroke and identifies promising areas for future research. #AHAJournals ahajrnls.org/4na5FCh

<a href="/NguyenThanhMD/">Thanh Nguyen 🇺🇦</a> @shadiyaghi2 <a href="/NicoleBSur/">Nicole B. Sur, MD</a> <a href="/BrownNeurology/">Brown Neurology</a>